Next - gen antibodies
Search documents
Sutro Biopharma (NasdaqGM:STRO) FY Conference Transcript
2025-12-03 21:32
Sutro Biopharma (NasdaqGM:STRO) FY Conference December 03, 2025 03:30 PM ET Company ParticipantsJonathan Fawcett - VP of Clinical DevelopmentJane Chung - CEOConference Call ParticipantsTed Tenthoff - Senior Biotech AnalystTed TenthoffTed Tenthoff, I'm a Senior Biotech Analyst at Piper Sandler. Before I begin, I'm required to point out certain disclosures regarding the relationship between Piper and our next presenting company, Sutro, which are posted at the back of the room and at the registration desk. Sut ...